We are live on ! Find out more
BIOL

Biolase, Inc.
BIOL

Delisted

BIOL was delisted on the 18th of June, 2024.

Back to rankings

13 hedge funds and large institutions have $12.2M invested in Biolase, Inc. in 2019 Q2 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 1 closing their positions.

New
Increased
Maintained
Reduced
Closed

200% more repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 1

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

7% less funds holding

Funds holding: 14 → 13 (-1)

37% less capital invested

Capital invested by funds: $19.4M → $12.2M (-$7.23M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 1

Holders
13
Holders Change
-1
Holders Change %
-7.14%
% of All Funds
0.28%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
–
Increased
3
Reduced
1
Closed
1
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.53M
2
ACM
Archon Capital Management
Washington
+$635K
3
BlackRock
BlackRock
New York
+$19.2K

Top Sellers

Rank Fund Capital Flow
1
OIM
Oracle Investment Management
Connecticut
-$1.92M
2
TRCT
Tower Research Capital (TRC)
New York
-$8K
Name Holding Trade Value Shares
Change 		Change in
Stake
OIM
1
Oracle Investment Management
Connecticut
$7.61M -$1.92M -400 -16%
ACM
2
Archon Capital Management
Washington
$2.29M +$635K +132 +27%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.41M +$1.53M +318 +489%
BlackRock
4
BlackRock
New York
$440K +$19.2K +4 +3%
TMC
5
Trellus Management Company
Florida
$171K – – –
Geode Capital Management
6
Geode Capital Management
Massachusetts
$68K – – –
Northern Trust
7
Northern Trust
Illinois
$53K – – –
California Public Employees Retirement System
8
California Public Employees Retirement System
California
$49K – – –
TA
9
Teton Advisors
New York
$32K – – –
Bank of New York Mellon
10
Bank of New York Mellon
New York
$16K – – –
Morgan Stanley
11
Morgan Stanley
New York
$14K – – –
UBS Group
12
UBS Group
Switzerland
$14K – – –
TFO
13
Tarbox Family Office
California
$11K – – –
LTFS
14
Ladenburg Thalmann Financial Services
Florida
$1K – – –
APA
15
American Portfolios Advisors
New York
$600 – – –
TRCT
16
Tower Research Capital (TRC)
New York
– -$8K -1 Closed

BIOL Hedge Fund Activity: Q2 2019 in Review

13 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Biolase, Inc. (BIOL) for Q2 2019, worth a combined $12.2M — down 37% from $19.4M a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of BIOL and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 3 added.

The largest buyer was Vanguard Group, adding an estimated $1.53M. The largest seller was Oracle Investment Management, cutting an estimated $1.92M.

  • 13 institutional investors held Biolase, Inc. (BIOL) as of Q2 2019, down from 14 in Q1 2019.
  • Funds reported $12.2M of Biolase, Inc. stock for Q2 2019, down 37% quarter-over-quarter.
  • 0 funds opened new Biolase, Inc. positions in Q2 2019 and 1 closed out, a net change of -1 holder.
  • The largest Biolase, Inc. buyer in Q2 2019 was Vanguard Group, an estimated $1.53M added.
  • The largest Biolase, Inc. seller in Q2 2019 was Oracle Investment Management, an estimated $1.92M sold.

Based on aggregated 13F filings for Q2 2019.